Castilia Life Sciences Private Limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
HIKAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Castilia Life Sciences Private Limited has filed a disclosure with the stock exchange under Regulation 10(6) of the SEBI Substantial Acquisition of Shares and Takeovers (SAST) Regulations, 2011. This filing reports an acquisition that was made by Castilia Life Sciences Private Limited in reliance on the exemption provided under Regulation 10 of the SAST Regulations. The specific details of the acquisition, including the number of shares acquired, the price, or the resulting shareholding percentage, are not disclosed in the headline. Regulation 10 generally provides exemptions from the mandatory open offer requirement for certain types of acquisitions, such as those within prescribed limits or under specific conditions.
This is a routine compliance filing under the takeover code for an acquisition made under a regulatory exemption. It does not indicate any immediate threat to existing shareholders or any major shift in control. Shareholders should look for the full disclosure document to understand the size and nature of the acquisition.